GE HealthCare Technologies Inc. (GEHC) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
Total Cash From Operating Activities Chart for GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHC) operating cash flow for FY2025 was USD 2.0B, a 1.9% change from FY2024. GE HealthCare Technologies Inc.'s operating cash flow grew from USD 2.0B in 2019 to USD 2.0B in 2025 (-0.1% over 6 years). Operating cash flow compound annual growth rate: 5-year CAGR of 3.3%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $31.98B
- Implied Share Price
- $70.31
- Enterprise Value
- $39.19B
- Revenue (TTM)
- $21.27B
- EBITDA
- $3.59B
- Profit Margin
- 9.33%
- Trailing P/E
- 16.16
- Forward P/E
- 13.83
- Price/Book (MRQ)
- 2.80
- Price/Sales (TTM)
- 1.50
- EV/EBITDA
- 10.61
- EV/Revenue
- 1.84
- Dividend Yield
- 0.20%
- Book Value
- $24.30
- Free Cash Flow (FY2025)
- $1.51B
- Free Cash Flow Yield
- 4.71%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.